Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients

INTRODUCTION: Gut microbiota has been implicated in the pharmacological activities of many natural products. As an effective hypolipidemic agent, berberine (BBR)’s clinical application is greatly impeded by the obvious inter-individual response variation. To date, little evidence exists on the causa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chongming, Zhao, Ying, Zhang, Yingying, Yang, Yanan, Su, Wenquan, Yang, Yuanyuan, Sun, Le, Zhang, Fang, Yu, Jiaqi, Wang, Yaoxian, Guo, Peng, Zhu, Baoli, Wu, Shengxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039652/
https://www.ncbi.nlm.nih.gov/pubmed/35499044
http://dx.doi.org/10.1016/j.jare.2021.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039652/
https://www.ncbi.nlm.nih.gov/pubmed/35499044
http://dx.doi.org/10.1016/j.jare.2021.07.011

Ejemplares similares